Sai Life Pharma Profile
Key Indicators
- Authorised Capital ₹ 20.00 Cr
as on 16-12-2024
- Paid Up Capital ₹ 11.51 Cr
as on 16-12-2024
- Company Age 5 Year, 1 Month
- Last Filing with ROC 31 Mar 2024
- Revenue 1251.55%
(FY 2024)
- Profit 281.35%
(FY 2024)
- Ebitda 24.36%
(FY 2024)
- Net Worth 0.23%
(FY 2024)
- Total Assets 5.83%
(FY 2024)
About Sai Life Pharma
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 20.00 Cr and a paid-up capital of Rs 11.51 Cr, as per Ministry of Corporate Affairs (MCA) records.
The Key Managerial Personnel (KMP) at Sai Life Pharma Private Limited India are Runa Karan as Company Secretary, Lakshminarayanan Chittor as Cfo, and Runa Karan as Company Secretary. Ranga Kanumuri, Krishnamraju Kanumuri, and Mitesh Daga serve as directors at the Company.
- CIN/LLPIN
U24290TG2019PTC136370
- Company No.
136370
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
25 Oct 2019
- Date of AGM
14 Jun 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Hyderabad
Industry
Company Details
- Location
Rangareddy, Telangana, India
- Telephone
- Email Address
- Website
- Social Media
Who are the key members and board of directors at Sai Life Pharma?
Executive Team (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Krishnamraju Kanumuri  | Managing Director | 25-Oct-2019 | Current |
| Runa Karan | Company Secretary | 01-Jul-2020 | Current |
Lakshminarayanan Chittor  | CFO | 01-Jul-2021 | Current |
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Ranga Kanumuri | Director | 25-Oct-2019 | Current |
| Mitesh Daga | Director | 09-Nov-2019 | Current |
Financial Performance and Corporate Structure Insights of Sai Life Pharma.
Sai Life Pharma Private Limited, for the financial year ended 2024, experienced significant growth in revenue, with a 1251.55% increase. The company also saw a substantial improvement in profitability, with a 281.35% increase in profit. The company's net worth moved up by a moderate rise of 0.23%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Sai Life Pharma?
In 2024, Sai Life Pharma had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Sai Life Sciences LimitedActive 25 years 10 monthsRanga Kanumuri, Krishnamraju Kanumuri and 4 more are mutual person
- South India Research Institute Pvt LtdActive 74 years 4 months
Krishnamraju Kanumuri is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Sai Life Pharma?
Unlock and access historical data on people associated with Sai Life Pharma, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Sai Life Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Sai Life Pharma's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
